Ignite Creation Date:
2024-05-06 @ 12:33 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03792568
Status:
UNKNOWN
Last Update Posted:
2019-02-15
First Post:
2019-01-02
Brief Title:
ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation
Sponsor:
Shanghai Changzheng Hospital
Organization:
Shanghai Changzheng Hospital
Organization Data
Organization:
Shanghai Changzheng Hospital
Class:
OTHER
Study ID:
AICAM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Changzheng Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhan Wang
Responsible Party Title:
ALK inhibitor in Metastatuc Colorectal Cancer with ALK mutation
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Changzheng Hospital
Old Name:
None
Old Organization:
None